Skip to main content

Advertisement

Log in

Regulatory T cells in type 1 diabetic patients with autoimmune chronic atrophic gastritis

  • Original Paper
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Type A chronic atrophic gastritis (CAG) is increased in type 1 diabetic patients (DM1). To address this issue, we determined and analyzed the number of peripheral blood regulatory T cells (Tregs) in 15 DM1-CAG patients, 15 DM1 patients without associated autoantibodies (DM1) and 15 healthy controls by flow cytometry and compared gastric Tregs expression (CD4+Foxp3+/CD4+) in DM1-CAG patients with that observed in 10 control Helicobacter pylori CAG-infected biopsies. The percentage of peripheral Tregs was higher in DM1-CAG patients compared to DM1 and controls (CD4+Foxp3+: 7.67 ± 1.91% vs. 5.38 ± 1.57% and 5.65 ± 1.76%, P < 0.001, respectively), with no differences between DM1 and controls. Gastric mucosal Tregs were higher in H. pylori CAG than in DM1-CAG patients (31.31 ± 5.52% vs. 7.68 ± 3.70%; P < 0.001). Data suggest that Tregs are stimulated in patients with more than one autoimmune disease (DM1 + CAG) in an ineffectual attempt to control autoimmune response and that the number of Tregs in gastric mucosa implicated in the chronification of gastritis differs according to the etiology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. M.A. Atkinson, G.S. Eisenbarth, Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358, 221–229 (2001)

    Article  CAS  PubMed  Google Scholar 

  2. J.A. Bluestone, Q. Tang, How do CD4+ CD25+ regulatory T cells control autoimmunity? Curr. Opin. Immunol. 17, 638–642 (2005)

    Article  CAS  PubMed  Google Scholar 

  3. E. Maggi, L. Cosmi, F. Liotta, P. Romagnani, S. Romagnani, F. Annunziato, Thymic regulatory T cells. Autoimmun. Rev. 4, 579–586 (2005)

    Article  CAS  PubMed  Google Scholar 

  4. S. Sakaguchi, N. Sakaguchi, M. Asano, M. Itoh, M. Toda, Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151 (1995)

    CAS  PubMed  Google Scholar 

  5. C.R. Ruprecht, M. Gattorno, F. Ferlito, A. Gregorio, A. Martini, A. Lanzavecchia, F. Sallusto, Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia. J. Exp. Med. 201, 1793–1803 (2005)

    Article  CAS  PubMed  Google Scholar 

  6. S. Hori, T. Nomura, S. Sakaguchi, Control of regulatory T cell development by the transcription factor foxp3. Science 299, 1057–1061 (2003)

    Article  CAS  PubMed  Google Scholar 

  7. W. Liu, A.M. Putnam, Z. Xu-Yu, G.L. Szot, M.R. Lee, S. Zhu, P.A. Gottlieb, P. Kapranov, T.R. Gingeras, B. Fazekas de St Groth, C. Clayberger, D.M. Soper, S.F. Ziegler, J.A. Bluestone, CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J. Exp. Med. 7, 1701–1711 (2006)

    Article  Google Scholar 

  8. R. Bacchetta, L. Passerini, E. Gambineri, M. Dai, S.E. Allan, L. Perroni, F. Dagna-Bricarelli, C. Sartirana, S. Matthes-Martin, A. Lawitschka, C. Azzari, S.F. Ziegler, M.K. Levings, M.G. Roncarolo, Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J. Clin. Invest. 116, 1713–1722 (2006)

    Article  CAS  PubMed  Google Scholar 

  9. S. Lindley, C.M. Dayan, A. Bishop, B.O. Roep, M. Peakman, T.I. Tree, Defective suppressor function in CD4+ CD25+ T-cells from patients with type 1 diabetes. Diabetes 54, 92–99 (2005)

    Article  CAS  PubMed  Google Scholar 

  10. A.L. Putnam, F. Vendrame, F. Dotta, P.A. Gottilieb, CD4+ CD25 high regulatory T cells in human autoimmune diabetes. J. Autoimmun. 24, 55–62 (2005)

    Article  CAS  PubMed  Google Scholar 

  11. T.M. Brusko, C.H. Wasserfall, M.J. Clare-Salzler, D.A. Schatz, M.A. Atkinson, Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in type 1 diabetes. Diabetes 54, 1407–1414 (2005)

    Article  CAS  PubMed  Google Scholar 

  12. T. Brusko, C. Wasserfall, K. McGrail, R. Schatz, H.L. Viener, D. Schatz, M. Haller, J. Rockell, P. Gottlieb, M. Clare-Salzler, M. Atkinson, No alterations in the frequency of Foxp3 + regulatory T-cells in type 1 diabetes. Diabetes 56, 604–612 (2007)

    Article  CAS  PubMed  Google Scholar 

  13. C. Betterle, F. Zanette, B. Pedini, F. Presotto, L.B. Rapp, C.M. Monciotti, F. Rigon, Clinical and subclinical organ-specific autoimmune manifestations in type 1 diabetic patients and their first-degree relatives. Diabetologia 26, 431–436 (1984)

    Article  CAS  PubMed  Google Scholar 

  14. J.M. Barker, Clinical review: type 1 diabetes-associated autoimmunity: natural history, genetic associations and screening. J. Clin. Endocrinol. Metab. 91, 1210–1217 (2006)

    Article  CAS  PubMed  Google Scholar 

  15. B.H. Toh, I.R. van Driel, P.A. Gleeson, Pernicious anemia. N. Engl. J. Med. 337, 1441–1448 (1997)

    Article  CAS  PubMed  Google Scholar 

  16. C. Hershko, A. Ronson, M. Souroujon, I. Maschler, J. Heyd, J. Patz, Variable hematologic presentation of autoimmune gastritis: age-related progression from iron deficiency to cobalamin depletion. Blood 107, 1673–1679 (2006)

    Article  CAS  PubMed  Google Scholar 

  17. C.E. De Block, I.H. De Leeuw, L.F. Van Gaal, High prevalence of manifestations of gastric autoimmunity in parietal cell antibody-positive type 1 (insulin-dependent) diabetic patients. The Belgian Diabetes Registry. J. Clin. Endocrinol. Metab. 84, 4062–4067 (1999)

    Article  PubMed  Google Scholar 

  18. C.E. De Block, I.H. De Leeuw, L.F. Van Gaal, Autoimmune gastritis in type 1 diabetes: a clinically oriented review. J. Clin. Endocrinol. Metab. 93, 363–371 (2008)

    Article  PubMed  Google Scholar 

  19. M. Asano, M. Toda, N. Sakaguchi, S. Sakaguchi, Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184, 387–396 (1996)

    Article  CAS  PubMed  Google Scholar 

  20. E. Suri-Payer, A.Z. Amar, A.M. Thornton, E.M. Shevach, CD4+ CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J. Immunol. 160, 1212–1218 (1998)

    CAS  PubMed  Google Scholar 

  21. K.L. Laurie, I.R. van Driel, P.A. Gleeson, The role of CD4+ CD25+ immunoregulatory T cells in the induction of autoimmune gastritis. Immunol. Cell Biol. 80, 567–573 (2002)

    Article  PubMed  Google Scholar 

  22. S. Sakaguchi, Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101, 455–458 (2000)

    Article  CAS  PubMed  Google Scholar 

  23. J. Haas, A. Hug, A. Viehöver, B. Fritzsching, C.S. Falk, A. Filser, T. Vetter, L. Milkova, M. Korporal, B. Fritz, B. Sotrch-Hagenlocher, P.H. Krammer, E. Suri-Payer, B. Wildemann, Reduced suppressive effect of CD4+ CD25 high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. Eur. J. Immunol. 35, 3343–3352 (2005)

    Article  CAS  PubMed  Google Scholar 

  24. M.A. Kriegel, T. Lohmann, C. Gabler, N. Blank, J.R. Kalden, H.M. Lorenz, Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II. J. Exp. Med. 199, 1285–1291 (2004)

    Article  CAS  PubMed  Google Scholar 

  25. A. Kukreja, G. Cost, J. Marker, C. Zhang, Z. Sun, K. Lin-Su, M. Sanz, M. Exley, B. Wilson, S. Porcelli, N. Maclaren, Multiple immuno-regulatory defects in type-1 diabetes. J. Clin. Invest. 109, 131–140 (2002)

    CAS  PubMed  Google Scholar 

  26. J. Maul, C. Loddenkemper, P. Mundt, E. Berg, T. Giese, A. Stallmach, M. Zeitz, R. Duchmann, Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease. Gastroenterology 128, 1868–1878 (2005)

    Article  CAS  PubMed  Google Scholar 

  27. X. Valencia, P.E. Lipsky, CD4+ CD25+ Foxp3+ regulatory T cells in autoimmune diseases. Nat. Clin. Pract. Rheumatol. 3, 619–626 (2007)

    Article  CAS  PubMed  Google Scholar 

  28. T.R. Torgerson, Regulatory T cells in human autoimmune diseases. Springer Semin. Immunopathol. 28, 63–76 (2006)

    Article  CAS  PubMed  Google Scholar 

  29. P. Achenbach, E. Bonifacio, K. Koczwara, A.G. Ziegler, Natural history of type 1 diabetes. Diabetes 54(2), 25–31 (2005)

    Article  Google Scholar 

  30. B. Seddon, D. Mason, Peripheral autoantigen induces regulatory T cells that prevent autoimmunity. J. Exp. Med. 189, 877–882 (1999)

    Article  CAS  PubMed  Google Scholar 

  31. V. Pillai, S.B. Ortega, C.K. Wang, N.J. Karandikar, Transient regulatory T-cells: a state attained by all activated human T-cells. Clin. Immunol. 123, 18–29 (2007)

    Article  CAS  PubMed  Google Scholar 

  32. D. Cao, V. Malmström, C. Baecher-Allan, D. Hafler, L. Klareskog, C. Trollmo, Isolation and functional characterization of regulatory CD25 bright CD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur. J. Immunol. 33, 215–223 (2003)

    Article  CAS  PubMed  Google Scholar 

  33. M. Marazuela, M.A. García-López, N. Figueroa-Vega, H. de la Fuente, B. Alvarado-Sánchez, A. Monsiváis-Urenda, F. Sánchez-Madrid, R. González-Amaro, Regulatory T cells in human autoimmune thyroid disease. J. Clin. Endocrinol. Metab. 91, 3639–3646 (2006)

    Article  CAS  PubMed  Google Scholar 

  34. A. Nakano, M. Watanabe, T. Iida, S. Kuroda, F. Matsuzuka, A. Miyauchi, Y. Iwatani, Apoptosis-induced decrease of intrathyroidal CD4+ CD25+ regulatory T cells in autoimmune thyroid diseases. Thyroid 17, 25–31 (2007)

    Article  CAS  PubMed  Google Scholar 

  35. A. Lundgren, E. Strömberg, A. Sjöling, C. Lindholm, K. Enarsson, A. Edebo, E. Johnsson, E. Suri-Payer, P. Larsson, A. Rudin, A.M. Svennerholm, B.S. Lundin, Mucosal Foxp3-expressing CD4+ CD25 high regulatory T cells in Helicobacter pylori-infected patients. Infect. Immun. 73, 523–531 (2005)

    Article  CAS  PubMed  Google Scholar 

  36. A. Schneider, C. Greenbaum, C. Pihoker, J. Buckner, Effector T cells of DM1 subjects are resistant to suppression by iTreg. Clin. Immunol. 127(1), 106 (2008)

    Article  Google Scholar 

  37. T. Korn, T. Reddy, N. Gao, E. Bettelli, A. Awasthi, T.R. Petersen, B.T. Bäckström, S.A. Sobel, K.W. Wucherpfennig, T.B. Strom, M. Oukka, V.K. Kuchroo, Myelin specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 13, 423–431 (2007)

    Article  CAS  PubMed  Google Scholar 

  38. N. Alonso, M.L. Granada, I. Salinas, A.M. Lucas, J.L. Reverter, J. Juncà, A. Oriol, A. Sanmartí, Serum pepsinogen I: an early marker of pernicious anaemia in patients with type 1 diabetes. J. Clin. Endocrinol. Metab. 90, 5254–5258 (2005)

    Article  CAS  PubMed  Google Scholar 

  39. N. Alonso, M.L. Granada, I. Salinas, J.L. Reverter, L. Flores, I. Ojanguren, E. Martínez-Cáceres, A. Sanmartí, Plasma ghrelin concentrations in type 1 diabetic patients with autoimmune atrophic gastritis. Eur. J. Endocrinol. 157, 763–769 (2007)

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Prof Ricardo Pujol: for helpful suggestions and critical reading of the manuscript; Prof Mercè Martí: for providing us with part of the monoclonal antibodies used in flow cytometric analysis; Diogo Baia, for technical support in the initial phases of the study and Christine 0’Hara for valuable help with the English version of the manuscript. This study was supported in part by the Instituto de Investigación Carlos III, grants FIS PI05/0150 to Dr. A. Sanmartí.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Núria Alonso.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alonso, N., Martínez-Arconada, M.J., Granada, M.L. et al. Regulatory T cells in type 1 diabetic patients with autoimmune chronic atrophic gastritis. Endocr 35, 420–428 (2009). https://doi.org/10.1007/s12020-009-9166-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-009-9166-2

Keywords

Navigation